IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,898 | $3,661 | $3,367 | $3,215 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Cost of Goods Sold | $1,519 | $1,471 | $1,363 | $1,326 |
| Gross Profit | $2,379 | $2,190 | $2,004 | $1,889 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| R&D Expenses | $220 | $191 | $255 | $161 |
| G&A Expenses | $442 | $336 | $326 | $310 |
| SG&A Expenses | $1,031 | $902 | $851 | $796 |
| Sales & Mktg Exp. | $589 | $566 | $525 | $487 |
| Other Operating Expenses | $0 | $0 | $2 | $1 |
| Operating Expenses | $1,251 | $1,093 | $1,106 | $957 |
| Operating Income | $1,128 | $1,097 | $899 | $932 |
| % Margin | 29% | 30% | 26.7% | 29% |
| Other Income/Exp. Net | -$19 | -$36 | -$39 | -$29 |
| Pre-Tax Income | $1,110 | $1,061 | $860 | $903 |
| Tax Expense | $222 | $216 | $181 | $158 |
| Net Income | $888 | $845 | $679 | $745 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS | 10.77 | 10.17 | 8.12 | 8.74 |
| % Growth | 5.9% | 25.2% | -7.1% | – |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| Weighted Avg Shares Out | 82 | 83 | 84 | 85 |
| Weighted Avg Shares Out Dil | 83 | 84 | 85 | 87 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13 | $6 | $1 | $0 |
| Interest Expense | $31 | $42 | $40 | $30 |
| Depreciation & Amortization | $130 | $115 | $112 | $105 |
| EBITDA | $1,276 | $1,218 | $1,015 | $1,040 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |